This Sources Sought opportunity from Department Of Defense was posted on September 11, 2020. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

BioFire Respiratory 2.1 (RP2.1) Panel with SARS-CoV-2 (COVID-19)

Closed

FA8052-20-RFI-BIOFIREFederal

Submission Closed09/13/2020, 09:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325413

New

SLED

First To Know Syphilis Tests and Controls Sets

Solicitation # QQ-130085

The Virginia Department of Health is soliciting quotes for First To Know Syphilis Tests and Controls manufactured by NowDiagnostics. The procurement includes 241 units of the Syphilis test kits (Item 8057-1-12), 145 units of the Convenience Pack (Item 8057-25-CP), and Non-assayed Syphilis Control Sets (Item 457.012). The contract is structured with four one-year renewal options, and the desired delivery time is 14 calendar days after receipt of order to a location in Henrico, Virginia. Bidders must provide a certified test report from a recognized laboratory and submit all proposals through the eVA portal. Award priority is given to DSBSD-certified micro and small businesses, including women-owned and minority-owned firms, provided the pricing is determined to be fair and reasonable. Proposals must remain valid for 90 days, and contractors are required to maintain specific insurance coverages authorized by the Virginia State Corporation Commission. Key technical requirements include the provision of Material Safety Data Sheets and adherence to strict storage protocols for control sets, which must be refrigerated at 2–8°C and not frozen. Payment is contingent upon the completion of installation, testing, and acceptance by the agency, with a standard payment term of 30 days.

Virginia Department of Health

POSTED

DEADLINE

Certified Industrial Wastewater Laboratory Testing

245-NETWORK Contract Office 5 (36C245)

POSTED

DEADLINE

Cost Per Reportable Result Purchase of Immunohistochemistry Reagents for Laboratory Tests.

Solicitation # 36C26027Q0058

The Department of Veterans Affairs, through Network Contracting Office 20, is seeking a comprehensive histology staining workflow system for the Puget Sound Health Care System in Seattle, Washington. The required system must include two immunohistochemistry and two in-situ hybridization immunostainers, two special stainers, and an integrated specimen tracking system to ensure patient safety, maintain a chain of custody, and monitor productivity. The workflow components must be fully automated, communicate with one another, and maintain compatibility with Data Innovations middleware as well as VISTA, Cerner, and any future electronic health record systems acquired by the VA. The contract follows a Cost Per Reportable Result pricing model and spans a base year from February 1, 2027, to January 31, 2028, with four subsequent one-year option periods extending through January 31, 2032. Technical requirements specify that the immunostainers must perform 100% of tests listed in the provided specifications and support simultaneous IHC, ISH, and Direct Immunofluorescence staining. Equipment must support Code 39 and Code 128 barcodes, include a safe hazardous waste removal system, and be provided with an uninterruptible power supply capable of supporting a 15-minute controlled shutdown. The contractor is responsible for the delivery, installation, and removal of equipment at no additional charge and must guarantee a minimum equipment uptime of 98%. Performance and method validation must adhere to CLSI guidelines and College of American Pathologists standards. Additionally, the contractor must comply with strict federal and VA information security directives, including those regarding data confidentiality and media sanitization. Emergency supply orders must be fulfilled within 24 hours of a verbal request, providing enough consumables for one week of normal operation.

260-NETWORK Contract Office 20 (36C260)

POSTED

DEADLINE

BPA - Consumable Supplies for Terumo Trima Accel Blood Collection systems

Solicitation # HT942627QE003

The Army Medical Resources Acquisition Activity is soliciting a Blanket Purchase Agreement (BPA) for the recurring resupply of consumable products for three Terumo Trima Accel Blood Collection Systems used by the USAISR Combat Casualty Care Research Team 1. To maintain FDA approval and operational requirements, the contractor must provide original manufacturer-supplied consumables, as no generic substitutes are available. Required supplies include Teruflex 500ml collection bags, Trima Platelet Kits, Isoplate Solution (PAS-F), TSCD Wafers, and ACD-A Solution. The contract is a 100 percent set-aside for Service-Disabled Veteran-Owned Small Businesses under NAICS code 325413. The BPA features a cumulative ceiling not to exceed 350,000 dollars over a 60-month ordering period, with individual call orders typically having a 12-month period of performance. Award will be made on a Lowest Price Technically Acceptable basis, with technical capability rated as either acceptable or unacceptable. Offerors must submit a two-volume quote by October 29, 2026, using the mandatory Exhibit A Pricing Sheet. Delivery is FOB Destination to Fort Sam Houston, Texas, and invoicing must be processed through the Wide Area WorkFlow system.

Army Medical Resources Acq Activity

POSTED

DEADLINE

6550--HEMOCHRON SIGNATURE ELITE REAGENTS AND SUPPLIES

Solicitation # 36C26227Q0046

The Department of Veterans Affairs, Network Contracting Office 22, is conducting a sources sought notice for the procurement of FDA approved reagents, supplies, consumables, and quality control materials for Werfen Hemochron Signature Elite instruments. This requirement supports the Pathology and Laboratory Medicine Service at the Southern Arizona VA Health Care System in Tucson, Arizona. The contract structure includes a base year from January 1, 2027, to December 31, 2028, followed by four subsequent option years extending through December 31, 2032. The selected contractor must provide 24/7 technical and product support at no additional cost and ensure all items are fully compatible with existing instrumentation without requiring workflow changes or retraining. Key operational requirements include strict adherence to manufacturer specifications for packaging and temperature control during transport. All supplied materials must maintain a minimum shelf life of 90 days, and shipments must clearly list lot numbers and expiration dates. Standard orders are required to be delivered within four working days, while emergency deliveries for defective or temperature-compromised items must be completed within 24 hours of a verbal order. This procurement is conducted as a brand name or equal acquisition under FAR 52.211-6. Interested respondents must provide their business size status, SAM.gov identifiers, and evidence of compliance with the Buy American Act and the Non-Manufacturer Rule.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

Solicitation # 2139989

The New York State Office of Mental Health, specifically for the Nathan S. Kline Institute in Rockland, has established a single-source procurement exemption to add drug abuse testing commodities to an existing contract. This action integrates tests previously purchased on a discretionary basis, adding a total of 185,000.00 dollars over three years, which averages 61,500.00 dollars annually. The procurement includes specific laboratory calibrators and controls, such as Syva Creatinine Validity Calibrators in various concentrations, Syva Validity Negative Calibrators, and EMIT Calibrators/Controls at levels 2 and 5. The contract term is effective from May 1, 2024, through April 30, 2029, with the agency planning to re-procure these services around the fall of 2028. Ron Foster, Contract Management Specialist 2, serves as the primary point of contact for this agreement. This procurement was processed as an exemption from advertising to ensure the necessary testing materials are formally incorporated into the agency's contractual framework.

NYS Office of Mental Health

POSTED

DEADLINE

Cepheid Reagents & Supplies for GeneXpert Testing Platform

Solicitation # 2140004

The State University of New York, specifically SUNY Stony Brook University Hospital, has issued solicitation number 2140004 for the procurement of Cepheid Reagents and Supplies for the GeneXpert Testing Platform. This procurement is categorized under Medical and Health Care Commodities and is designated as a sole or single source procurement exempt from advertising. The request was formally approved by the Office of the State Comptroller on October 14, 2026, under NYS Contract Reporter Exemption Request SNY01-0004719-3320215 (CRER-0469C). The contract term is established from October 13, 2025, through October 12, 2027, with the place of performance located at Stony Brook University Hospital state-wide. The primary point of contact for this action is Zhong Yi Hu. The notice was posted on October 16, 2026, with an advertisement end date of October 23, 2026. No specific contract value or pricing details were provided in the documentation.

State University of New York (SUNY)

POSTED

DEADLINE

TEST KIT, CORONAVIRUS D

Solicitation # SPE2DS-27-T-0714

Solicitation SPE2DS-27-T-0714 is issued by the Defense Logistics Agency for the procurement of one case of Abbott BinaxNOW COVID-19 Antigen self-test kits for over-the-counter, at-home use. Each case contains 12 kits with 2 tests per kit. The items must be stored between 2 and 30 degrees Celsius and must have a non-extendable shelf life of 12 months, with no more than one month elapsed from the date of manufacture to the date of delivery. Delivery is required within 20 days after receipt of order, with the FOB and inspection/acceptance points set to destination. The contractor must adhere to Medical Marking Standard No. 1 for all labeling, ensuring the inclusion of the contract or lot number and the manufacture, expiration, or retest date. Packaging must be commercial, utilizing sealed unit containers and suitable exterior shipping containers in accordance with DLA packaging requirements and MIL-STD-2073-1E. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and compliance with the Buy American and Balance of Payments Program. The solicitation is categorized under NAICS code 325413 and incorporates various FAR and DFARS clauses regarding cybersecurity, safeguarding covered defense information, and the HUBZone price evaluation preference.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Antibody Identification Panel CellsThis subcontract involves the manufacture and delivery of antibody identification panel cells for prime contractors supporting Department of Veterans Affairs Network Contract Office 20 medical supply projects. These red blood cell reagents are critical for matching donated blood products to recipients within Surgery, Oncology, Emergency, and Medical Units, with shipments specifically destined for the Boise VA Medical Center. The provider must maintain strict compliance with clinical standards and hold Federal Supply Schedule status under Group 66 III Cat 605-2A. Operating under NAICS code 325413, the contract is managed by the Department of Veterans Affairs with performance associated with the Vancouver area.

260-NETWORK Contract Office 20 (36C260)

POSTED

DEADLINE

Supply of Quality Control Check CellsThis subcontract involves the manufacture and delivery of specialized red blood cell quality control check cells for the Department of Veterans Affairs Network Contract Office 20. These reagents are critical for validating patient testing within the Transfusion Services Department and are delivered specifically to the Boise VA Medical Center. The provider must maintain strict quality control standards and hold Federal Supply Schedule status under Group 66 III Cat 605-2A. Operating under NAICS code 325413, the contract ensures that prime contractors on medical supply projects have the necessary materials to maintain clinical accuracy and regulatory compliance.

260-NETWORK Contract Office 20 (36C260)

POSTED

DEADLINE

Q301--VA Boise, Idaho - Blood Bank Reagents Requirement

Solicitation # 36C26027Q0082

The Department of Veterans Affairs, through Network Contracting Office 20, has issued a pre-solicitation notice for the procurement of red blood cell reagents to support the Transfusion Services Department at the Boise, Idaho VA Medical Center. This requirement falls under NAICS code 325413 for In-Vitro Diagnostic Substance Manufacturing. The scope of work involves the supply of quality control check cells and antibody identification panel cells that adhere to strict quality control and compliance standards for patient testing. These reagents are critical for matching donated blood products to recipients in various hospital departments, including Surgery, Oncology, Emergency, and Medical Units. This notice is intended for market research and planning purposes and does not constitute a formal Request for Quotation or a commitment to contract. Interested parties must submit a response by October 26, 2026, at 16:00 PT to Contract Specialist Andrew O'Neal. Required submissions include company contact information, DUNS number, business size and socioeconomic status, a statement regarding Federal Supply Schedule status under Group 66 III Cat 605-2A, and a capability statement not exceeding three pages demonstrating the necessary resources, personnel, and experience to fulfill the requirement.

260-NETWORK Contract Office 20 (36C260)

POSTED

DEADLINE

KKH_KRFP261018_Medsupplies_Detection of DNA of BV and CV associated pathogens and TV kit with Free on Loan Equipment

Solicitation # Doc2439781197

KK Women’s and Children’s Hospital, through contracting agent ALPS Pte Ltd, is seeking proposals for the supply of detection kits for DNA of BV and CV associated pathogens and TV, including free on loan equipment. This term contract spans an initial five years with an option to extend for an additional three years. Eligible participants must be locally registered companies, and those providing medical devices must hold GDPMDS certification and ensure all devices are registered with the Health Science Authority of Singapore. The scope of supply includes delivery for consumables, as well as delivery, installation, integration, testing, and commissioning for any equipment provided. Interested vendors must submit their entire response via Ariba Sourcing between October 16, 2026, and October 30, 2026, at 3:00pm Singapore Time. Submissions through other channels may lead to disqualification, and suppliers are encouraged to use generic company email addresses for all event notifications.

ALPS Pte. Ltd.

POSTED

5 days ago

DEADLINE

in 10 days

General Info

Agency

Department Of Defense → FA8052 773 Ess

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Place of Performance

Set-Aside

NONE

Documents

Justification+and+Approval_REDACTED.pdf

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseClosed

PostedSep 11

Sources Sought

Response DeadlineSep 13

Deadline has passed

Submission Closed

09/13/2020, 09:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → FA8052 773 Ess

Contacts2 people available

OfficeSAN ANTONIO, TX, 78236-0119, USA

Organization / AgencyDepartment Of Defense → FA8052 773 Ess

Office AddressSAN ANTONIO, TX, 78236-0119, USA

Contacts

Nathaniel W. Trulove

Larry Conger

Full Description

General Information THIS IS A REQUEST FOR INFORMATION (RFI)/SOURCES SOUGHT ANNOUNCEMENT to conduct market research relative to a requirement for BioFire Respiratory 2.1 (RP2.1) Panel with SARS-CoV-2. This RFI announcement is NOT a Request for Proposal (RFP) and the Government is not committed to award a contract pursuant to this announcement. The information from this RFI is for planning purposes only and will assist the Government in planning its acquisition strategy and is not to be construed as a commitment by the Government, implied or otherwise, to issue a solicitation or ultimately award a contract. General Intent The Air Force is looking to award a single contract to facilitate this requirement. This market research is being conducted to assist in determining the best acquisition strategy for the subject BioFire Respiratory 2.1 (RP2.1) Panel with SARS-CoV-2. Any information regarding contract type, commercial practices, and specifications are requested and being considered for the development of the solicitation. This announcement is targeted for all qualified businesses that can provide the product as stated in the product description; responses from all interested parties are appreciated and accepted. Description This is a product description BioFire Respiratory 2.1 (RP2.1) Panel with SARS-CoV-2. The BioFire Respiratory 2.1 (RP2.1) Panel with SARS-CoV-2 should not only detect SARS-CoV-2, but also detect 21 additional respiratory pathogens to help clinicians quickly rule in and rule out other common causes of respiratory illness. Furthermore, the BioFire Respiratory 2.1 (RP2.1) Panel with SARS-CoV-2 shall be compatible for use on both the BioFire 2.0, BioFire Torch, and/or any other BioFire analyzer. Background AFMS requires access to BioFire Respiratory 2.1 (RP2.1) Panel with SARS-CoV-2 (COVID-19) Virus due to worldwide pandemic. This requirement provides for RP2.1 Panels in support of 73 BioFire FilmArray and 7 Torch analyzers across 42 Military Treatment Facilities in place for Home Station Medical Response programs, negating the need for mass equipment purchases. The ability to test for COVID-19 Virus on the BioFire analyzers is delivered via the reagent RP2.1 Panel. Without access to the appropriate reagent RP2.1 Panels the Air Force faces mission degradation across every MAJCOM. BioFire RP2.1 Panels are the only reagents compatible with BioFire FilmArray and/or Torch Analyzers. The BioFire FilmArray and Torch systems are not open platform molecular instruments, so other tests/reagents will not work on BioFire instrumentation. The FilmArray and Torch systems utilize a very specific - pouch which in a fully automated fashion purifies the sample, extracts the nucleic acids, conducts a reverse transcriptase step to convert target RNA into DNA, does multiplex PCR, nested singleplex PCR, and finally a melting curve analysis and automated results reporting. The pouches are proprietary to BioFire and are not produced by other companies. BioFire is therefore considered sole source for FilmArray and Torch tests. The 773d Enterprise Sourcing Squadron (773 ESS) is seeking responses to the questions listed below. Please provide your responses on company letterhead to the Point of Contact (POC) identified at the end of this RFI. 1. Please provide your company's name, mailing address, Cage Code, Data Universal Numbering System (DUNS) identification number, Point of Contact (POC), telephone number and e-mail address. Please also provide the name of the company's Parent Company, if applicable. 2. Please provide your business size status (i.e. 8(a) Business Development Small Business Certification, Historically Underutilized Business Zone (HUBZone), Woman- Owned Small Business (WOSB) or Service Disabled Veteran-Owned Small Business (SDCOSB), Small Business, Large Business, etc.) under NAICS 325413. *If you are under the 8(a) program, please identify when you graduate from the program. 3. Given the product description, if you feel another NAICS code better fits this requirement, please identify that. 4. Based on the product description, do you have enough information to provide an accurate proposal? If not, what additional information can the Government provide to assist you in creating a more accurate proposal? 5. Identify any factors that likely contribute risk or uncertainty to developing a proposal for this proposed requirement. Please rate any factors you identify as either high or low regarding the degree of risk to the contractor. For the high risk drivers, please explain why the risk is high and suggest how the Government might mitigate or reduce this risk. 6. Do any components of the product description conflict with standard industry practice? If so, please describe. 7. Would your company be interested in participating in this requirement? Please provide any additional questions, comments, concerns, etc. you have concerning this proposed acquisition. Provide feedback on whether the objectives, requirements, and other information presented in the product description are clear and achievable, and provide suggested changes, as appropriate.